(Q34655385)

English

Matrix metalloproteinases and atherosclerotic plaque instability

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

1 reference

Europe PubMed Central

Matrix metalloproteinases and atherosclerotic plaque instability (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

Ian M Loftus

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

A R Naylor

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

P R F Bell

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

M M Thompson

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

British Journal of Surgery

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

89

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

680-694

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The matrix metalloproteinases and their inhibitors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Wound fluid from chronic leg ulcers contains elevated levels of metalloproteinases MMP-2 and MMP-9.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

The role of inflammatory mediators in the pathogenesis of periodontal disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Rheumatoid arthritis. Pathophysiology and implications for therapy

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Matrix metalloproteinase inhibitors: present achievements and future prospects

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Coronary Plaque Disruption

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Matrix metalloproteinases and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Matrix metalloproteinases: implication in vascular matrix remodelling during atherogenesis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Multiple modes of activation of latent human fibroblast collagenase: evidence for the role of a Cys73 active-site zinc complex in latency and a "cysteine switch" mechanism for activation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

The family of matrix metalloproteinases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

A sequence-tagged site map of human chromosome 11.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Matrix metalloproteinase gene expression

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

A matrix metalloproteinase expressed on the surface of invasive tumour cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Cytokine regulation of metalloproteinase gene expression

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

The purification of tissue inhibitor of metalloproteinases-2 from its 72 kDa progelatinase complex. Demonstration of the biochemical similarities of tissue inhibitor of metalloproteinases-2 and tissue inhibitor of metalloproteinases-1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Hypercholesterolemia increases endothelial superoxide anion production

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Tissue inhibitors of matrix metalloendopeptidases

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Elevated white blood cell count and carotid plaque thickness : the northern manhattan stroke study.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

C-reactive protein in ischemic stroke: an independent prognostic factor.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Regulation of matrix metalloproteinase activity in ischemic tissue by interleukin-10: role in ischemia-induced angiogenesis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Serum levels of the antiinflammatory cytokine interleukin-10 are decreased in patients with unstable angina

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Membrane type 1 matrix metalloproteinase expression in human atherosclerotic plaques: evidence for activation by proinflammatory mediators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Matrilysin is expressed by lipid-laden macrophages at sites of potential rupture in atherosclerotic lesions and localizes to areas of versican deposition, a proteoglycan substrate for the enzyme

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Identification of matrix metalloproteinases 3 (stromelysin-1) and 9 (gelatinase B) in abdominal aortic aneurysm

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Coexpression of integrin alpha(v)beta3 and matrix metalloproteinase-2 (MMP-2) coincides with MMP-2 activation: correlation with melanoma progression

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

TACE and other ADAM proteases as targets for drug discovery

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

The new kids on the block: ADAMTSs, potentially multifunctional metalloproteinases of the ADAM family

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Regulation of matrix metalloproteinase expression in human vascular smooth muscle cells by T lymphocytes: a role for CD40 signaling in plaque rupture?

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

CD40 on human endothelial cells: inducibility by cytokines and functional regulation of adhesion molecule expression.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Reduction of atherosclerosis in mice by inhibition of CD40 signalling

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

CD40 signaling and plaque instability

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

That impish TIMP: the tissue inhibitor of metalloproteinases-3

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Novel clinical markers of vascular wall inflammation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Peripheral blood levels of matrix metalloproteases-2 and -9 are elevated in patients with acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

A binding site for SH3 domains targets dynamin to coated pits

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Functional Polymorphism in the Regulatory Region of Gelatinase B Gene in Relation to Severity of Coronary Atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Local overexpression of TIMP-1 prevents aortic aneurysm degeneration and rupture in a rat model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Therapeutic effect of the matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Experimental and clinical studies on the use of matrix metalloproteinase inhibitors for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Blocking periodontal disease progression by inhibiting tissue-destructive enzymes: a potential therapeutic role for tetracyclines and their chemically-modified analogs.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Uptake of tetracycline by aortic aneurysm wall and its effect on inflammation and proteolysis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

The influence of indomethacin on the metabolism and cytokine secretion of human aneurysmal aorta

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Natural statins and stroke risk.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Effects of lipid-lowering by simvastatin on human atherosclerotic lesions: a longitudinal study by high-resolution, noninvasive magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Effects of oxidized low density lipoprotein, lipid mediators and statins on vascular cell interactions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Statins alter smooth muscle cell accumulation and collagen content in established atheroma of watanabe heritable hyperlipidemic rabbits

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Rapid reduction in C-reactive protein with cerivastatin among 785 patients with primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Marimastat inhibits elastin degradation and matrix metalloproteinase 2 activity in a model of aneurysm disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Stromelysin-1 and Interleukin-6 Gene Promoter Polymorphisms Are Determinants of Asymptomatic Carotid Artery Atherosclerosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2168.2002.02099.X

21 January 2018

Identifiers

10.1046/J.1365-2168.2002.02099.X

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34655385&oldid=1619097109"